FemHealth Ventures and Warren Point Capital led a $53m Series D round in GT Medical Technologies.

FemHealth Ventures and Warren Point Capital, venture capital firms, led a $53m Series D round in GT Medical Technologies, a medical device company. "Increasing the size of the Series D allows us to stay focused on driving results for patients into the foreseeable future. We are thankful for our investors' continued support as we expand our commercial footprint and clinical initiatives for GammaTile," Per Langoe, GT Medical Technologies CEO.